Danaher Corporation

Danaher Corporation

Global leader in diagnostics and water quality

About Danaher Corporation

Simplify's Rating
Why Danaher Corporation is rated
A+
Rated A on Competitive Edge
Rated A+ on Growth Potential
Rated A+ on Rating Differentiation

Industries

Industrial & Manufacturing

Healthcare

Consumer Goods

Company Size

10,001+

Company Stage

IPO

Total Funding

N/A

Headquarters

Washington, District of Columbia

Founded

1969

Overview

Danaher Corporation operates in water quality, product identification, and diagnostics, providing precision instruments and purification technologies for analyzing and managing water safety. In product identification, it leads in laser marking and coding technologies that ensure accurate labeling and tracking of products. The company also offers advanced diagnostic tools and software to enhance healthcare providers' ability to deliver effective care. Danaher distinguishes itself through its Danaher Business System, which promotes continuous improvement and has significantly contributed to its financial success.

Simplify Jobs

Simplify's Take

What believers are saying

  • AI-driven diagnostics tools enhance Danaher's healthcare offerings and diagnostic accuracy.
  • Growing demand for sustainable water management boosts Danaher's water quality segment.
  • Decentralized healthcare trends increase demand for Danaher's point-of-care diagnostic solutions.

What critics are saying

  • Increased competition from AI startups like Mistral AI challenges Danaher's market position.
  • Healthcare AI companies like Innovaccer pose threats to Danaher's diagnostics segment.
  • Integration challenges from acquiring GE Life Sciences' Biopharma business may impact efficiency.

What makes Danaher Corporation unique

  • Danaher's Danaher Business System drives continuous improvement and superior financial performance.
  • The company excels in water quality, diagnostics, and product identification technologies.
  • Danaher offers cutting-edge diagnostic tools enhancing diagnostic confidence and patient health.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$0

Below

Industry Average

Funded Over

1 Rounds

Post IPO Equity funding comparison data is currently unavailable. We're working to provide this information soon!
Post IPO Equity Funding Comparison
Coming Soon

Company News

PR Newswire
Feb 20th, 2025
Danaher Announces Appointment Of Charles Lamanna To Danaher Board

WASHINGTON, Feb. 20, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that it has appointed Charles Lamanna to its Board of Directors and to the Board's Science & Technology Committee.Mr. Lamanna is currently Corporate Vice President, Business & Industry Copilot at Microsoft (NASDAQ: MSFT), where he drives product innovation in AI-powered business applications, low-code platforms, and autonomous agents. He oversees the design, product development, and engineering of some of Microsoft's most transformative technologies, including Power Platform, Dynamics 365, and Copilot Studio. Prior to that, Mr. Lamanna was the founder and CEO of MetricsHub, one of the first public cloud management solutions, which Microsoft acquired in 2013.Mr

PR Newswire
Feb 20th, 2025
Danaher Increases Quarterly Dividend

WASHINGTON, Feb. 20, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.32 per share of its common stock, payable on April 25, 2025 to holders of record on March 28, 2025. This reflects an 18.5% increase over the previous dividend payment of $0.27.ABOUT DANAHERDanaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Our businesses partner closely with customers to solve many of the most important health challenges impacting patients around the world. Danaher's advanced science and technology - and proven ability to innovate - help enable faster, more accurate diagnoses and help reduce the time and cost needed to sustainably discover, develop and deliver life-changing therapies. Focused on scientific excellence, innovation and continuous improvement, our approximately 63,000 associates worldwide help ensure that Danaher is improving quality of life for billions of people today, while setting the foundation for a healthier, more sustainable tomorrow

PR Newswire
Jan 29th, 2025
Danaher Reports Fourth Quarter And Full Year 2024 Results

WASHINGTON, Jan. 29, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the fourth quarter and full year 2024.  All results in this release reflect only continuing operations unless otherwise noted. Key Fourth Quarter 2024 Results Net earnings were $1.1 billion, or $1.49 per diluted common share and non-GAAP adjusted diluted net earnings per common share were $2.14. Revenues increased 2.0% year-over-year to $6.5 billion and non-GAAP core revenue increased 1.0%

PYMNTS
Jan 21st, 2025
Ai Startups: Mistral Plans Ipo; Harvey Eyes $3 Billion Valuation

Mistral AI, France’s open-source answer to OpenAI, plans to go public instead of being acquired. “We are not for sale,” CEO and co-founder Arthur Mensch told Bloomberg TV Tuesday (Jan. 21). There had been speculation that the startup would be acquired by Microsoft, in part due to a partnership and the tech giant’s investment of 15 million euros ($15.6 million) in Mistral. (Microsoft has invested nearly $14 billion in OpenAI.)

PR Newswire
Jan 13th, 2025
Danaher Ceo To Comment On Financial Performance

WASHINGTON, Jan. 13, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") announced that its President and Chief Executive Officer, Rainer M. Blair, will comment tomorrow on the Company's fourth quarter 2024 performance in a presentation at the J.P. Morgan Healthcare Conference at 11:15 a.m. PT. For the fourth quarter 2024, estimated revenues are anticipated to increase in the low-single digit percent range year-over-year

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for Danaher Corporation right now.

Find jobs on Simplify and start your career today

💡
We update Danaher Corporation's jobs every 8 hours, so check again soon! Browse all jobs →